Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Wnt modulating agents inhibit human cytomegalovirus replication.

Kapoor A, He R, Venkatadri R, Forman M, Arav-Boger R.

Antimicrob Agents Chemother. 2013 Jun;57(6):2761-7. doi: 10.1128/AAC.00029-13. Epub 2013 Apr 9.

2.

Human cytomegalovirus inhibition by cardiac glycosides: evidence for involvement of the HERG gene.

Kapoor A, Cai H, Forman M, He R, Shamay M, Arav-Boger R.

Antimicrob Agents Chemother. 2012 Sep;56(9):4891-9. doi: 10.1128/AAC.00898-12. Epub 2012 Jul 9.

3.

Establishment of a cell-based assay for screening of compounds inhibiting very early events in the cytomegalovirus replication cycle and characterization of a compound identified using the assay.

Fukui Y, Shindoh K, Yamamoto Y, Koyano S, Kosugi I, Yamaguchi T, Kurane I, Inoue N.

Antimicrob Agents Chemother. 2008 Jul;52(7):2420-7. doi: 10.1128/AAC.00134-08. Epub 2008 May 5.

4.

Efficacy and Mechanism of Action of Low Dose Emetine against Human Cytomegalovirus.

Mukhopadhyay R, Roy S, Venkatadri R, Su YP, Ye W, Barnaeva E, Mathews Griner L, Southall N, Hu X, Wang AQ, Xu X, Dulcey AE, Marugan JJ, Ferrer M, Arav-Boger R.

PLoS Pathog. 2016 Jun 23;12(6):e1005717. doi: 10.1371/journal.ppat.1005717. eCollection 2016 Jun.

6.

The c-Jun N-terminal kinase inhibitor SP600125 inhibits human cytomegalovirus replication.

Zhang H, Niu X, Qian Z, Qian J, Xuan B.

J Med Virol. 2015 Dec;87(12):2135-44. doi: 10.1002/jmv.24286. Epub 2015 Jun 16.

PMID:
26058558
7.
9.

Phosphorothioate-modified oligodeoxynucleotides inhibit human cytomegalovirus replication by blocking virus entry.

Luganini A, Caposio P, Landolfo S, Gribaudo G.

Antimicrob Agents Chemother. 2008 Mar;52(3):1111-20. doi: 10.1128/AAC.00987-07. Epub 2008 Jan 7.

10.

The human cytomegalovirus UL112-113 locus can activate the full Kaposi's sarcoma-associated herpesvirus lytic replication cycle.

Wells R, Stensland L, Vieira J.

J Virol. 2009 May;83(9):4695-9. doi: 10.1128/JVI.02241-08. Epub 2009 Feb 11.

11.
12.
14.

Kinome Profiling Identifies Druggable Targets for Novel Human Cytomegalovirus (HCMV) Antivirals.

Arend KC, Lenarcic EM, Vincent HA, Rashid N, Lazear E, McDonald IM, Gilbert TS, East MP, Herring LE, Johnson GL, Graves LM, Moorman NJ.

Mol Cell Proteomics. 2017 Apr;16(4 suppl 1):S263-S276. doi: 10.1074/mcp.M116.065375. Epub 2017 Feb 25.

PMID:
28237943
15.

Monensin and nigericin prevent the inhibition of host translation by poliovirus, without affecting p220 cleavage.

Irurzun A, Sánchez-Palomino S, Novoa I, Carrasco L.

J Virol. 1995 Dec;69(12):7453-60.

16.

Inhibition by monensin of human cytomegalovirus DNA replication.

Kaiser CJ, Radsak K.

Arch Virol. 1987;94(3-4):229-45.

PMID:
3034210
17.

Indolocarbazoles: potent, selective inhibitors of human cytomegalovirus replication.

Slater MJ, Cockerill S, Baxter R, Bonser RW, Gohil K, Gowrie C, Robinson JE, Littler E, Parry N, Randall R, Snowden W.

Bioorg Med Chem. 1999 Jun;7(6):1067-74.

PMID:
10428375
18.

The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein.

Loregian A, Mercorelli B, Muratore G, Sinigalia E, Pagni S, Massari S, Gribaudo G, Gatto B, Palumbo M, Tabarrini O, Cecchetti V, Palù G.

Antimicrob Agents Chemother. 2010 May;54(5):1930-40. doi: 10.1128/AAC.01730-09. Epub 2010 Mar 1.

19.

Inhibitory effects of tricin derivative from Sasa albo-marginata on replication of human cytomegalovirus.

Akuzawa K, Yamada R, Li Z, Li Y, Sadanari H, Matsubara K, Watanabe K, Koketsu M, Tuchida Y, Murayama T.

Antiviral Res. 2011 Sep;91(3):296-303. doi: 10.1016/j.antiviral.2011.06.014. Epub 2011 Jul 2.

PMID:
21745500
20.

Trehalose, an mTOR-Independent Inducer of Autophagy, Inhibits Human Cytomegalovirus Infection in Multiple Cell Types.

Belzile JP, Sabalza M, Craig M, Clark E, Morello CS, Spector DH.

J Virol. 2015 Nov 11;90(3):1259-77. doi: 10.1128/JVI.02651-15.

Supplemental Content

Support Center